Oliver Dorigo, M.D., Ph.D.

Professor of Obstetrics and Gynecology (Oncology)

Clinical Focus

Cancer > Gynecologic Cancer
Gynecologic Oncology

Academic Appointments

Professor - University Medical Line, Obstetrics & Gynecology - Gynecologic Oncology
Member, Bio-X
Member, Stanford Cancer Institute

Administrative Appointments

Director, Stanford Gynecologic Oncology Fellowship (2016 - Present)
Director, Stanford Clinical Research Group for Gynecologic Cancer Trials (2014 - Present)
Director, Stanford Gynecologic Oncology Clinical Care Program (2013 - Present)
Director, Mary Lake Polan Gynecologic Oncology Research Laboratory (2013 - Present)
Director, Stanford Obstetrics and Gynecology, Division of Gynecologic Oncology (2013 - Present)

Honors & Awards

American Association of Cancer Research Outstanding Poster Award, Toronto, Canada, American Association of Cancer Research, Toronto, Canada (1995)
Outstanding Podium Presentation Award, National Gynecologic Oncology Fellow’s Forum (2004)
Teaching Award, National Council on Resident Education in Obstetrics and Gynecology (2007)
STOP Cancer Career Development Award, STOP Cancer (2008)
OB/GYN Resident Teaching Award, University of California, Los Angeles (2008)

Boards, Advisory Committees, Professional Organizations

Member, Society of Pelvic Surgeons (2016 - Present)
Member, American Association of Cancer Research (1996 - Present)
Member, American Gynecological and Obstetrical Society (2016 - Present)
Member, Society of Gynecologic Investigations (2000 - Present)
Member, American Society of Gene Therapy (2000 - Present)
Member, Society of Gynecologic Oncology (2005 - Present)
Member, Gynecologic Oncology Group (2005 - Present)

Professional Education

Fellowship: UCLA Medical Center Obstetrics and Gynecology Fellowships (2005) CA
Residency: UCLA Medical Center Obstetrics and Gynecology Residency (1999) CA
Medical Education: University of Heidelberg (1989) Germany
Board Certification: American Board of Obstetrics and Gynecology, Gynecologic Oncology (2008)
Board Certification: American Board of Obstetrics and Gynecology, Obstetrics and Gynecology (2006)
PhD, University of California, Los Angeles, Molecular Biology (2003)
Residency: Ludwig Maximillians University (1992) Germany

Contact

Academic odorigo@stanford.edu

Alternate Contact Helen Wong Administrative Assistant hswong@stanford.edu Tel: (650) 724-0456

Clinical Stanford Women's Cancer Center 900 Blake Wilbur Dr 1st Fl MC 5854 Palo Alto CA 94304 Tel: (650) 498-6004 Fax: (650) 498-7237

2023-24 Courses

Independent Studies
- Directed Reading in Obstetrics and Gynecology
  OBGYN 299 (Win, Spr)
- Early Clinical Experience in Obstetrics and Gynecology
  OBGYN 280 (Win, Spr)
- Graduate Research in Reproductive Biology
  OBGYN 399 (Win, Spr)
- Medical Scholars Research
  OBGYN 370 (Aut, Win, Spr)
- Undergraduate Research in Reproductive Biology
  OBGYN 199 (Win, Spr)

Stanford Advisees

Postdoctoral Faculty Sponsor
Huyen Pham

All Publications

Profiles With Related Publications

close
Ranjana Advani

Saul A. Rosenberg, MD, Professor of Lymphoma
Clinical Focus
Cancer > Lymphoma, Burkitt's Lymphoma, Hodgkin's Disease, Investigational Therapeutics, Lymphoma , Mycosis Fungoides, Non-Hodgkin's Lymphoma, Oncology (Cancer), Plasmacytoma, Waldenstrom's Macroglobulinemia , Medical Oncology
Research Interests
Clinical investigation in Hodgkin's disease, non-Hodgkin's Lymphomas and cutaneous lymphomas. Experimental therapeutics with novel chemotherapy and biologically targeted therapies.

The research program is highly collaborative with radiation oncology, industry, pathology and dermatology.

648 Total Publications
close
Jonathan S. Berek, MD, MMSc

Laurie Kraus Lacob Professor
Clinical Focus
Cancer > Gynecologic Cancer, Gynecologic Cancers - Gynecologic Oncology, Ovarian Cancer, Uterine Cancer, Uterine Cervical Cancer, Vaginal Cancer, Vulvar Cancer, Trophoblastic Neoplasms, Pelvic Reconstructive Surgery, Neovagina, Obstetrics and Gynecology

317 Total Publications
close
Robert W. Carlson

Professor of Medicine (Oncology and General Internal Medicine/Medical Informatics) at the Stanford University Medical Center, Emeritus
Research Interests
Clinical investigations in breast cancer include institutional and NSABP studies of chemoprevention, adjuvant therapy, psychosocial interventions, treatment of metastatic disease, methods of decreasing anthracycline cardiotoxicity, and modulation of multidrug resistance. Research in meta-analysis includes the performance of meta-analysis in a wide variety of settings in cancer treatment by the international Meta-Analysis Group in Cancer.

166 Total Publications
close
Christopher H. Contag

Professor of Pediatrics (Neonatology), Emeritus
Research Interests
We develop and use the tools of molecular imaging to understand oncogenesis, reveal patterns of cell migration in immunosurveillance, monitor gene expression, visualize stem cell biology, and assess the distribution of pathogens in living animal models of human biology and disease. Biology doesn't occur in "a vacuum" or on coated plates--it occurs in the living body and that's were we look for biological patterns and responses to insult.

350 Total Publications
close
Fei Dong

Clinical Instructor, Pathology
Clinical Focus
Molecular Pathology, Anatomic Pathology

68 Total Publications
close
Edgar Engleman

Professor of Pathology and of Medicine (Immunology and Rheumatology)
Research Interests
Dendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.

286 Total Publications
close
C. Garrison Fathman

Professor of Medicine (Immunology and Rheumatology), Emeritus
Research Interests
My lab of molecular and cellular immunology is interested in research in the general field of T cell activation and autoimmunity. We have identified and characterized a gene (GRAIL) that seems to control regulatory T cell (Treg) responsiveness by inhibiting the Treg IL-2 receptor desensitization. We have characterized a gene (Deaf1) that plays a major role in peripheral tolerance in T1D. Using PBC gene expression, we have provisionally identified a signature of risk and progression in T1D.

326 Total Publications
close
James Ford

Professor of Medicine (Oncology) and of Genetics and, by courtesy, of Pediatrics
Clinical Focus
Cancer > GI Oncology, Cancer Genetics, Gastrointestinal Cancers - Genetics, Gastrointestinal Cancers - Medical Oncology, Breast Cancer - Genetics, Ovarian Cancer - Genetics, Medical Oncology, Molecular Tumor Board
Research Interests
Mammalian DNA repair and DNA damage inducible responses; p53 tumor suppressor gene; transcription in nucleotide excision repair and mutagenesis; genetic determinants of cancer cell sensitivity to DNAdamage; genetics of inherited cancer susceptibility syndromes and human GI malignancies; clinical cancer genetics of BRCA1 and BRCA2 breast cancer and mismatch repair deficient colon cancer.

297 Total Publications
close
Amato J. Giaccia

Jack, Lulu and Sam Willson Professor, Professor of Radiation Oncology, Emeritus
Research Interests
During the last five years, we have identified several small molecules that kill VHL deficient renal cancer cells through a synthetic lethal screening approach. Another major interest of my laboratory is in identifying hypoxia-induced genes involved in invasion and metastases. We are also investigating how hypoxia regulates gene expression epigenetically.

403 Total Publications
close
Amer Karam

Clinical Professor, Obstetrics & Gynecology - Gynecologic Oncology
Clinical Focus
Cancer > Gynecologic Cancer, Gynecologic Oncology

63 Total Publications
close
Mark A. Kay, M.D., Ph.D.

Dennis Farrey Family Professor of Pediatrics, and Professor of Genetics
Research Interests
Mark A. Kay, M.D., Ph.D. Director of the Program in Human Gene Therapy and Professor in the Departments of Pediatrics and Genetics. Respected worldwide for his work in gene therapy for hemophilia, Dr. Kay and his laboratory focus on establishing the scientific principles and developing the technologies needed for achieving persistent and therapeutic levels of gene expression in vivo. The major disease models are hemophilia, hepatitis C, and hepatitis B viral infections.

440 Total Publications
close
Susan Knox

Associate Professor of Radiation Oncology, Emerita
Research Interests
Our interests include 1) study of the effect of radiation on regulatory cell subpopulations and co-stimulatory molecules, 2) use of radiation as an immune modulator for optimization of transplant regimens, 3) the role of radiation in tumor vaccine strategies, 4) study of new radiosensitizers and radioprotectors, and 5) discovery of new targeted therapies for the treatment of solid tumors.

233 Total Publications